Proton radiobiology

Cancers

Volumn 7, Issue 1, 2015, Pages 353-381

  Tommasino, Francesco ^a   Durante, Marco ^a,b  

^a GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biological range; Proton therapy; Radiobiology; RBE; Target fragmentation

Indexed keywords

DOUBLE STRANDED DNA;

CANCER RADIOTHERAPY; CELL MIGRATION; DOUBLE STRANDED DNA BREAK; HUMAN; INFLAMMATION; ION THERAPY; METASTASIS; PHOTON THERAPY; PROTON THERAPY; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION HAZARD; RADIATION RESPONSE; RELATIVE BIOLOGIC EFFECTIVENESS; REVIEW; TREATMENT PLANNING; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

EID: 84924536219     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers7010353     Document Type: Review

References (127)

1. Jermann, M. Particle therapy statistics in 2013. Int. J. Part. Ther. 2014, 1, 40-43.
2. Loeffler, J.S.; Durante, M. Charged particle therapy--optimization, challenges and future directions. Nat. Rev. Clin. Oncol. 2013, 10, 411-424.
3. Lomax, A.J.; Bortfeld, T.; Goitein, G.; Debus, J.; Dykstra, C.; Tercier, P.A.; Coucke, P.A.; Mirimanoff, R.O. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother. Oncol. 1999, 51, 257-271.
4. Paganetti, H.; Niemierko, A.; Ancukiewicz, M.; Gerweck, L.E.; Goitein, M.; Loeffler, J.S.; Suit, H.D. Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53, 407-421.
5. Goodhead, D.T. Energy deposition stochastics and track structure: What about the target? Radiat. Prot. Dosimetry. 2006, 122, 3-15.
6. Paganetti, H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys. Med. Biol. 2014, 59, R419-R472.
7. Friedrich, T.; Scholz, U.; Elsässer, T.; Durante, M.; Scholz, M. Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J. Radiat. Res. 2012, doi:10.1093/jrr/rrs114.
8. Sinclair, W.K. The shape of radiation survival curves of mammalian cells cultured in vitro. In Biophysical Aspects of Radiation Quality, Technical Reports Series No. 58; IAEA: Vienna, Austria, 1966.
9. Paganetti, H.; van Luijk, P. Biological considerations when comparing proton therapy with photon therapy. Semin. Radiat. Oncol. 2013, 23, 77-87.
10. Prise, K.M.; O’Sullivan, J.M. Radiation-induced bystander signalling in cancer therapy. Nat. Rev. Cancer 2009, 9, 351-360.
11. Girdhani, S.; Lamont, C.; Hahnfeldt, P.; Abdollahi, A.; Hlatky, L. Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth. Radiat. Res. 2012, 178, 33-45.
12. Girdhani, S.; Sachs, R.; Hlatky, L. Biological effects of proton radiation: What we know and don’t know. Radiat. Res. 2013, 179, 257-272.
13. Ding, L.H.; Park, S.; Peyton, M.; Girard, L.; Xie, Y.; Minna, J.D.; Story, M.D. Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to gamma-rays and different elemental particles of high Z and energy. BMC. Genomics 2013, 14, 372.
14. Scholz, M.; Kellerer, A.M.; Kraft-Weyrather, W.; Kraft, G. Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat. Environ. Biophys. 1997, 36, 59-66.
15. Elsässer, T.; Weyrather, W.K.; Friedrich, T.; Durante, M.; Iancu, G.; Krämer, M.; Kragl, G.; Brons, S.; Winter, M.; Weber, K.J., et al. Quantification of the relative biological effectiveness for ion beam radiotherapy: Direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, 1177-1183.
16. Dasu, A.; Toma-Dasu, I. Impact of variable RBE on proton fractionation. Med. Phys. 2013, 40, 011705.
17. Chaudhary, P.; Marshall, T.I.; Perozziello, F.M.; Manti, L.; Currell, F.J.; Hanton, F.; McMahon, S.J.; Kavanagh, J.N.; Cirrone, G.A.; Romano, F., et al. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int. J. Radiat. Oncol. Biol. Phys. 2014, 90, 27-35.
18. Grassberger, C.; Paganetti, H. Elevated LET components in clinical proton beams. Phys. Med. Biol. 2011, 56, 6677-6691.
19. Belli, M.; Cherubini, R.; Dalla, V.M.; Dini, V.; Esposito, G.; Moschini, G.; Sapora, O.; Simone, G.; Tabocchini, M.A. DNA fragmentation in V79 cells irradiated with light ions as measured by pulsed-field gel electrophoresis. I. Experimental results. Int. J. Radiat. Biol. 2002, 78, 475-482.
20. Calugaru, V.; Nauraye, C.; Noel, G.; Giocanti, N.; Favaudon, V.; Megnin-Chanet, F. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81, 1136-1143.
21. Hada, M.; Sutherland, B.M. Spectrum of complex DNA damages depends on the incident radiation. Radiat. Res. 2006, 165, 223-230.
22. Leloup, C.; Garty, G.; Assaf, G.; Cristovao, A.; Breskin, A.; Chechik, R.; Shchemelinin, S.; Paz-Elizur, T.; Livneh, Z.; Schulte, R.W., et al. Evaluation of lesion clustering in irradiated plasmid DNA. Int. J. Radiat. Biol. 2005, 81, 41-54.
23. Grosse, N.; Fontana, A.O.; Hug, E.B.; Lomax, A.; Coray, A.; Augsburger, M.; Paganetti, H.; Sartori, A.A.; Pruschy, M. Deficiency in homologous recombination renders Mammalian cells more sensitive to proton vs. photon irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2014, 88, 175-181.
24. Finnberg, N.; Wambi, C.; Ware, J.H.; Kennedy, A.R.; El-Deiry, W.S. Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol. Ther. 2008, 7, 2023-2033.
25. Gerelchuluun, A.; Hong, Z.; Sun, L.; Suzuki, K.; Terunuma, T.; Yasuoka, K.; Sakae, T.; Moritake, T.; Tsuboi, K. Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines. Int. J. Radiat. Biol. 2011, 87, 57-70.
26. Green, L.M.; Murray, D.K.; Bant, A.M.; Kazarians, G.; Moyers, M.F.; Nelson, G.A.; Tran, D.T. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis, cell survival, and cell cycle phase redistribution. Radiat. Res. 2001, 155, 32-42.
27. Costes, S.V.; Boissiere, A.; Ravani, S.; Romano, R.; Parvin, B.; Barcellos-Hoff, M.H. Imaging features that discriminate between foci induced by high-and low-LET radiation in human fibroblasts. Radiat. Res. 2006, 165, 505-515.
28. Desai, N.; Davis, E.; O’Neill, P.; Durante, M.; Cucinotta, F.A.; Wu, H. Immunofluorescence detection of clustered gamma-H2AX foci induced by HZE-particle radiation. Radiat. Res. 2005, 164, 518-522.
29. Leatherbarrow, E.L.; Harper, J.V.; Cucinotta, F.A.; O’Neill, P. Induction and quantification of gamma-H2AX foci following low and high LET-irradiation. Int. J. Radiat. Biol. 2006, 82, 111-118.
30. Goetz, W.; Morgan, M.N.; Baulch, J.E. The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat. Res. 2011, 175, 575-587.
31. Esteller, M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8, 286-298.
32. Di Pietro, C.; Piro, S.; Tabbi, G.; Ragusa, M.; di Pietro, V.; Zimmitti, V.; Cuda, F.; Anello, M.; Consoli, U.; Salinaro, E.T., et al. Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy. Apoptosis 2006, 11, 57-66.
33. Lee, K.B.; Lee, J.S.; Park, J.W.; Huh, T.L.; Lee, Y.M. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp. Mol. Med. 2008, 40, 118-129.
34. Giedzinski, E.; Rola, R.; Fike, J.R.; Limoli, C.L. Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons. Radiat. Res. 2005, 164, 540-544.
35. Zhang, X.; Lin, S.H.; Fang, B.; Gillin, M.; Mohan, R.; Chang, J.Y. Therapy-resistant cancer stem cells have differing sensitivity to photon vs. proton beam radiation. J. Thorac. Oncol. 2013, 8, 1484-1491.
36. Mishra, K.P. Cell membrane oxidative damage induced by gamma-radiation and apoptotic sensitivity. J. Environ. Pathol. Toxicol. Oncol. 2004, 23, 61-66.
37. Agrawal, A.; Kale, R.K. Radiation induced peroxidative damage: Mechanism and significance. Indian J. Exp. Biol. 2001, 39, 291-309.
38. Somosy, Z. Radiation response of cell organelles. Micron 2000, 31, 165-181.
39. Benderitter, M.; Vincent-Genod, L.; Pouget, J.P.; Voisin, P. The cell membrane as a biosensor of oxidative stress induced by radiation exposure: A multiparameter investigation. Radiat. Res. 2003, 159, 471-483.
40. Baluchamy, S.; Ravichandran, P.; Periyakaruppan, A.; Ramesh, V.; Hall, J.C.; Zhang, Y.; Jejelowo, O.; Gridley, D.S.; Wu, H.; Ramesh, G.T. Induction of cell death through alteration of oxidants and antioxidants in lung epithelial cells exposed to high energy protons. J. Biol. Chem. 2010, 285, 24769-24774.
41. Luotola, J. Membrane damage caused by free radicals—Radiation perspective. Med. Biol. 1984, 62, 115-118.
42. Durante, M. New challenges in high-energy particle radiobiology. Br. J. Radiol. 2014, 87, 20130626.
43. Das, A.K.; Bell, M.H.; Nirodi, C.S.; Story, M.D.; Minna, J.D. Radiogenomics predicting tumor responses to radiotherapy in lung cancer. Semin. Radiat. Oncol. 2010, 20, 149-155.
44. Raju, M.R. Proton radiobiology, radiosurgery and radiotherapy. Int. J. Radiat. Biol. 1995, 67, 237-259.
45. Gerweck, L.E.; Kozin, S.V. Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 1999, 50, 135-142.
46. Belli, M.; Bettega, D.; Calzolari, P.; Cera, F.; Cherubini, R.; Dalla, V.M.; Durante, M.; Favaretto, S.; Gialanella, G.; Grossi, G., et al. Inactivation of human normal and tumour cells irradiated with low energy protons. Int. J. Radiat. Biol. 2000, 76, 831-839.
47. Bettega, D.; Calzolari, P.; Chauvel, P.; Courdi, A.; Herault, J.; Iborra, N.; Marchesini, R.; Massariello, P.; Poli, G.L.; Tallone, L. Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. Int. J. Radiat. Biol. 2000, 76, 1297-1303.
48. Tang, J.T.; Inoue, T.; Inoue, T.; Yamazaki, H.; Fukushima, S.; Fournier-Bidoz, N.; Koizumi, M.; Ozeki, S.; Hatanaka, K. Comparison of radiobiological effective depths in 65-MeV modulated proton beams. Br. J. Cancer 1997, 76, 220-225.
49. Brahme, A. Development of radiation therapy optimization. Acta Oncol. 2000, 39, 579-595.
50. Wedenberg, M.; Lind, B.K.; Hardemark, B. A model for the relative biological effectiveness of protons: The tissue specific parameter alpha/beta of photons is a predictor for the sensitivity to LET changes. Acta Oncol. 2013, 52, 580-588.
51. Chen, Y.; Ahmad, S. Empirical model estimation of relative biological effectiveness for proton beam therapy. Radiat. Prot. Dosim. 2012, 149, 116-123.
52. Frese, M.C.; Wilkens, J.J.; Huber, P.E.; Jensen, A.D.; Oelfke, U.; Taheri-Kadkhoda, Z. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 80-88.
53. Frese, M.C.; Yu, V.K.; Stewart, R.D.; Carlson, D.J. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83, 442-450.
54. Hawkins, R.B. A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET. Med. Phys. 1998, 25, 1157-1170.
55. Carabe, A.; Moteabbed, M.; Depauw, N.; Schuemann, J.; Paganetti, H. Range uncertainty in proton therapy due to variable biological effectiveness. Phys. Med. Biol. 2012, 57, 1159-1172.
56. Tilly, N.; Johansson, J.; Isacsson, U.; Medin, J.; Blomquist, E.; Grusell, E.; Glimelius, B. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys. Med. Biol. 2005, 50, 2765-2777.
57. Brown, J.M.; Attardi, L.D. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5, 231-237.
58. Green, L.M.; Tran, D.T.; Murray, D.K.; Rightnar, S.S.; Todd, S.; Nelson, G.A. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation: II. The role of connexin 32. Radiat. Res. 2002, 158, 475-485.
59. Ristic-Fira, A.M.; Todorovic, D.V.; Koricanac, L.B.; Petrovic, I.M.; Valastro, L.M.; Cirrone, P.G.; Raffaele, L.; Cuttone, G. Response of a human melanoma cell line to low and high ionizing radiation. Ann. NY Acad. Sci. 2007, 1095, 165-174.
60. Narang, H.; Bhat, N.; Gupta, S.K.; Santra, S.; Choudhary, R.K.; Kailash, S.; Krishna, M. Differential activation of mitogen-activated protein kinases following high and low LET radiation in murine macrophage cell line. Mol. Cell Biochem. 2009, 324, 85-91.
61. Moertel, H.; Georgi, J.C.; Distel, L.; Eyrich, W.; Fritsch, M.; Grabenbauer, G.; Sauer, R. Effects of low energy protons on clonogenic survival, DSB repair and cell cycle in human glioblastoma cells and B14 fibroblasts. Radiother. Oncol. 2004, 73, S115-S118.
62. Antoccia, A.; Sgura, A.; Berardinelli, F.; Cavinato, M.; Cherubini, R.; Gerardi, S.; Tanzarella, C. Cell cycle perturbations and genotoxic effects in human primary fibroblasts induced by low-energy protons and X/gamma-rays. J. Radiat. Res. 2009, 50, 457-468.
63. Carmeliet, P.; Jain, R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407, 249-257.
64. Paganetti, H. Significance and implementation of RBE variations in proton beam therapy. Technol. Cancer Res. Treat. 2003, 2, 413-426.
65. Moeller, B.J.; Cao, Y.; Li, C.Y.; Dewhirst, M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5, 429-441.
66. Sonveaux, P.; Brouet, A.; Havaux, X.; Gregoire, V.; Dessy, C.; Balligand, J.L.; Feron, O. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: Implications for tumor radiotherapy. Cancer Res. 2003, 63, 1012-1019.
67. Park, C.M.; Park, M.J.; Kwak, H.J.; Lee, H.C.; Kim, M.S.; Lee, S.H.; Park, I.C.; Rhee, C.H.; Hong, S.I. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 2006, 66, 8511-8519.
68. Ogata, T.; Teshima, T.; Kagawa, K.; Hishikawa, Y.; Takahashi, Y.; Kawaguchi, A.; Suzumoto, Y.; Nojima, K.; Furusawa, Y.; Matsuura, N. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005, 65, 113-120.
69. Bernier, J.; Bentzen, S.M.; Vermorken, J.B. Molecular therapy in head and neck oncology. Nat. Rev. Clin. Oncol. 2009, 6, 266-277.
70. Takahashi, Y.; Teshima, T.; Kawaguchi, N.; Hamada, Y.; Mori, S.; Madachi, A.; Ikeda, S.; Mizuno, H.; Ogata, T.; Nojima, K., et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 2003, 63, 4253-4257.
71. Jang, G.H.; Ha, J.H.; Huh, T.L.; Lee, Y.M. Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos. Arch. Pharm. Res. 2008, 31, 779-785.
72. Gridley, D.S.; Bonnet, R.B.; Bush, D.A.; Franke, C.; Cheek, G.A.; Slater, J.D.; Slater, J.M. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60, 759-766.
73. Kajioka, E.H.; Andres, M.L.; Mao, X.W.; Moyers, M.F.; Nelson, G.A.; Gridley, D.S. Hematological and TGF-beta variations after whole-body proton irradiation. Vivo 2000, 14, 703-708.
74. Rithidech, K.N.; Reungpatthanaphong, P.; Honikel, L.; Rusek, A.; Simon, S.R. Dose-rate effects of protons on in vivo activation of nuclear factor-kappa B and cytokines in mouse bone marrow cells. Radiat. Environ. Biophys. 2010, 49, 405-419.
75. Chang, P.Y.; Bjornstad, K.A.; Rosen, C.J.; Lin, S.; Blakely, E.A. Particle radiation alters expression of matrix metalloproteases resulting in ECM remodeling in human lens cells. Radiat. Environ. Biophys. 2007, 46, 187-194.
76. McNamara, M.P.; Bjornstad, K.A.; Chang, P.Y.; Chou, W.; Lockett, S.J.; Blakely, E.A. Modulation of lens cell adhesion molecules by particle beams. Phys. Med. 2001, 17, S247-S248.
77. Tian, J.; Pecaut, M.J.; Coutrakon, G.B.; Slater, J.M.; Gridley, D.S. Response of extracellular matrix regulators in mouse lung after exposure to photons, protons and simulated solar particle event protons. Radiat. Res. 2009, 172, 30-41.
78. Hei, T.K.; Zhou, H.; Ivanov, V.N.; Hong, M.; Lieberman, H.B.; Brenner, D.J.; Amundson, S.A.; Geard, C.R. Mechanism of radiation-induced bystander effects: A unifying model. J. Pharm. Pharmacol. 2008, 60, 943-950.
79. Lorimore, S.A.; Chrystal, J.A.; Robinson, J.I.; Coates, P.J.; Wright, E.G. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res. 2008, 68, 8122-8126.
80. Lorimore, S.A.; Mukherjee, D.; Robinson, J.I.; Chrystal, J.A.; Wright, E.G. Long-lived inflammatory signaling in irradiated bone marrow is genome dependent. Cancer Res. 2011, 71, 6485-6491.
81. Shiraishi, K.; Ishiwata, Y.; Nakagawa, K.; Yokochi, S.; Taruki, C.; Akuta, T.; Ohtomo, K.; Matsushima, K.; Tamatani, T.; Kanegasaki, S. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin. Cancer Res. 2008, 14, 1159-1166.
82. Hiniker, S.M.; Chen, D.S.; Knox, S.J. Abscopal effect in a patient with melanoma. N. Engl. J. Med. 2012, 366, 2035-2036.
83. Postow, M.A.; Callahan, M.K.; Barker, C.A.; Yamada, Y.; Yuan, J.; Kitano, S.; Mu, Z.; Rasalan, T.; Adamow, M.; Ritter, E., et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 2012, 366, 925-931.
84. Durante, M.; Reppingen, N.; Held, K.D. Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol. Med. 2013, 19, 565-582.
85. Gragoudas, E.S.; Lane, A.M.; Munzenrider, J.; Egan, K.M.; Li, W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans. Am. Ophthalmol. Soc. 2002, 100, 43-48.
86. Munzenrider, J.E.; Verhey, L.J.; Gragoudas, E.S.; Seddon, J.M.; Urie, M.; Gentry, R.; Birnbaum, S.; Ruotolo, D.M.; Crowell, C.; McManus, P., et al. Conservative treatment of uveal melanoma: Local recurrence after proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 1989, 17, 493-498.
87. Marucci, L.; Lane, A.; Li, W.; Egan, K.; Gragoudas, E.; Adams, J.; Collier, J.; Munzenrider, J.E. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64, 1018-1022.
88. Sethi, R.V.; Giantsoudi, D.; Raiford, M.; Malhi, I.; Niemierko, A.; Rapalino, O.; Caruso, P.; Yock, T.I.; Tarbell, N.J.; Paganetti, H., et al. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int. J. Radiat. Oncol. Biol. Phys. 2014, 88, 655-663.
89. Schneider, U.; Lomax, A.; Timmermann, B. Second cancers in children treated with modern radiotherapy techniques. Radiother. Oncol. 2008, 89, 135-140.
90. Sethi, R.V.; Shih, H.A.; Yeap, B.Y.; Mouw, K.W.; Petersen, R.; Kim, D.Y.; Munzenrider, J.E.; Grabowski, E.; Rodriguez-Galindo, C.; Yock, T.I., et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer 2014, 120, 126-133.
91. Chung, C.S.; Yock, T.I.; Nelson, K.; Xu, Y.; Keating, N.L.; Tarbell, N.J. Incidence of second malignancies among patients treated with proton vs. photon radiation. Int. J. Radiat. Oncol. Biol. Phys. 2013, 87, 46-52.
92. Newhauser, W.D.; Durante, M. Assessing the risk of second malignancies after modern radiotherapy. Nat. Rev. Cancer 2011, 11, 438-448.
93. Moyers, M.F.; Miller, D.W.; Bush, D.A.; Slater, J.D. Methodologies and tools for proton beam design for lung tumors. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49, 1429-1438.
94. Goitein, M. Calculation of the uncertainty in the dose delivered during radiation therapy. Med. Phys. 1985, 12, 608-612.
95. Paganetti, H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys. Med. Biol. 2012, 57, R99-R117.
96. Tang, S.; Both, S.; Bentefour, H.; Paly, J.J.; Tochner, Z.; Efstathiou, J.; Lu, H.M. Improvement of prostate treatment by anterior proton fields. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83, 408-418.
97. Jakel, O.; Reiss, P. The influence of metal artefacts on the range of ion beams. Phys. Med. Biol. 2007, 52, 635-644.
98. Newhauser, W.; Fontenot, J.; Koch, N.; Dong, L.; Lee, A.; Zheng, Y.; Waters, L.; Mohan, R. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys. Med. Biol. 2007, 52, 2937-2952.
99. Schneider, U.; Pedroni, E.; Lomax, A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys. Med. Biol. 1996, 41, 111-124.
100. Schneider, W.; Bortfeld, T.; Schlegel, W. Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys. Med. Biol. 2000, 45, 459-478.
101. Albertini, F.; Bolsi, A.; Lomax, A.J.; Rutz, H.P.; Timmerman, B.; Goitein, G. Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother. Oncol. 2008, 86, 187-194.
102. Knopf, A.C.; Lomax, A. In vivo proton range verification: A review. Phys. Med. Biol. 2013, 58, R131-R160.
103. Grün, R.; Friedrich, T.; Krämer, M.; Zink, K.; Durante, M.; Engenhart-Cabillic, R.; Scholz, M. Biologically effective proton range analysis. Med. Phys. 2013, 40, 1-10.
104. Johansson, J. Comparative Treatment Planning in Radiotherapy and Clinical Impact of Proton Relative Biological Effectiveness; Acta Universitatis Upsaliensis: Uppsala, Sweden, 2006; p. 62.
105. Gensheimer, M.F.; Yock, T.I.; Liebsch, N.J.; Sharp, G.C.; Paganetti, H.; Madan, N.; Grant, P.E.; Bortfeld, T. In vivo proton beam range verification using spine MRI changes. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, 268-275.
106. Carlson, B.V. Microscopic abrasion-ablation approximation to projectile fragmentation. Phys. Rev. C. Nucl. Phys. 1995, 51, 252-268.
107. Carlson, B.V.; Mastroleo, R.C.; Hussein, M.S. Fragment production in heavy-ion reactions. Phys. Rev. C. 1992, 46, R30-R33.
108. Bradt, H.L.; Peters, B. The heavy nuclei of the primary cosmic radiation. Phys. Rev. 1950, 77, 54-76.
109. Sihver, L.; Tsao, C.H.; Silberberg, R.; Kanai, T.; Barghouty, A.F. Total reaction and partial cross section calculations in proton-nucleus (Zt ≤ 26) and nucleus-nucleus reactions (Zp and Zt ≤ 26). Phys. Rev. C 1993, 47, 1225-1236.
110. Durante, M.; Cucinotta, F.A. Physical basis of radiation protection in space travel. Rev. Mod. Phys. 2011, 83, 1245-1281.
111. Bichsel, H. Stochastics of energy loss and biological effects of heavy ions in radiation therapy. Adv. Quantum Chem. 2013, 65, 1-38.
112. Goldhaber, A.S. Statistical models of fragmentation processes. Phys. Lett. 1974, 53B, 306-308.
113. Giacomelli, M.; Sihver, L.; Skvarc, J.; Yasuda, N.; Ilic, R. Projectile like fragment emission angles in fragmentation reactions of light heavy ions in the energy region <200 MeV/nucleon: Modeling and simulations. Phys. Rev. C 2004, 69, 064601.
114. Paganetti, H. Nuclear interactions in proton therapy: Dose and relative biological effect distributions originating from primary and secondary particles. Phys. Med. Biol. 2002, 47, 747-764.
115. Krämer, M.; Durante, M. Ion beam transport calculations and treatment plans in particle therapy. Eur. Phys. J. D 2010, 60, 195-202.
116. Krämer, M.; Scifoni, E.; Schmitz, F.; Sokol, O.; Durante, M. Overview of recent advances in treatment planning for ion beam radiotherapy. Eur. Phys. J. D 2014, 68, 306-311.
117. Sihver, L.; Lantz, M.; Böhlen, T.T.; Mairani, A.; Cerutti, A.F.; Ferrari, A. A comparison of total reaction cross section models used in FLUKA, GEANT4 and PHITS. In Proceedings of the IEEE Aerospace Conference, Big Sky, MT, USA, 3-10 March 2012; pp. 1-10.
118. Böhlen, T.T.; Cerutti, F.; Dosanjh, M.; Ferrari, A.; Gudowska, I.; Mairani, A.; Quesada, J.M. Benchmarking nuclear models of FLUKA and GEANT4 for carbon ion therapy. Phys. Med. Biol. 2010, 55, 5833-5847.
119. Carlsson, C.A.; Carlsson, G.A. Proton dosimetry with 185 MeV protons. Dose buildup from secondary protons and recoil electrons. Health Phys. 1977, 33, 481-484.
120. Cucinotta, F.A.; Katz, R.; Wilson, J.W.; Townsend, L.W.; Shinn, J.; Hajnal, F. Biological effectiveness of high-energy protons: Target fragmentation. Radiat. Res. 1991, 127, 130-137.
121. Butts, J.J.; Katz, R. Theory of RBE for heavy ion bombardment of dry enzymes and viruses. Radiat. Res. 1967, 30, 855-871.
122. Katz, R.; Sharma, S.C. Heavy particles in therapy: An application of track theory. Phys. Med. Biol. 1974, 19, 413-435.
123. Gueulette, J.; Bohm, L.; de Coster, B.M.; Vynckier, S.; Octave-Prignot, M.; Schreuder, A.N.; Symons, J.E.; Jones, D.T.; Wambersie, A.; Scalliet, P. RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa). Radiother. Oncol. 1997, 42, 303-309.
124. Ando, K.; Koike, S.; Uzawa, A.; Takai, N.; Fukawa, T.; Furusawa, Y.; Aoki, M.; Miyato, Y. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J. Radiat. Res. 2005, 46, 51-57.
125. Karger, C.P.; Peschke, P.; Sanchez-Brandelik, R.; Scholz, M.; Debus, J. Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: Experimental results and clinical implications. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66, 1488-1497.
126. Wedenberg, M.; Toma-Dasu, I. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans. Med. Phys. 2014, 41, 091706.
127. Niemierko, A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med. Phys. 1997, 24, 103-110.